- Home
- VTYX vs RITR Comparison
VTYX vs RITR Comparison
Compare VTYX & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- RITR
- Stock Information
- Founded
- VTYX 2018
- RITR 2015
- Country
- VTYX United States
- RITR Hong Kong
- Employees
- VTYX N/A
- RITR N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- RITR
- Sector
- VTYX Health Care
- RITR
- Exchange
- VTYX Nasdaq
- RITR NYSE
- Market Cap
- VTYX 154.9M
- RITR 166.1M
- IPO Year
- VTYX 2021
- RITR 2024
- Fundamental
- Price
- VTYX $1.61
- RITR $2.78
- Analyst Decision
- VTYX Buy
- RITR
- Analyst Count
- VTYX 4
- RITR 0
- Target Price
- VTYX $11.33
- RITR N/A
- AVG Volume (30 Days)
- VTYX 1.3M
- RITR 190.1K
- Earning Date
- VTYX 03-04-2025
- RITR 02-15-2025
- Dividend Yield
- VTYX N/A
- RITR N/A
- EPS Growth
- VTYX N/A
- RITR N/A
- EPS
- VTYX N/A
- RITR 0.09
- Revenue
- VTYX N/A
- RITR $47,948,887.00
- Revenue This Year
- VTYX N/A
- RITR N/A
- Revenue Next Year
- VTYX N/A
- RITR N/A
- P/E Ratio
- VTYX N/A
- RITR $32.16
- Revenue Growth
- VTYX N/A
- RITR 278.44
- 52 Week Low
- VTYX $1.57
- RITR $2.24
- 52 Week High
- VTYX $11.48
- RITR $8.75
- Technical
- Relative Strength Index (RSI)
- VTYX 34.49
- RITR N/A
- Support Level
- VTYX $1.57
- RITR N/A
- Resistance Level
- VTYX $1.78
- RITR N/A
- Average True Range (ATR)
- VTYX 0.10
- RITR 0.00
- MACD
- VTYX -0.00
- RITR 0.00
- Stochastic Oscillator
- VTYX 10.26
- RITR 0.00
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About RITR REITAR LOGTECH HLDGS LTD
Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.